Sign In
Buy FBIO
$2.61
-0.0400 (-1.51%)
At Close: Jun 03, 2026
Reata Pharmaceuticals, Inc. (RETA) Reports Q2 Loss, Lags Revenue Estimates
11:55am, Monday, 08'th Aug 2022 Zacks Investment Research
Reata Pharmaceuticals, Inc. (RETA) delivered earnings and revenue surprises of -6.32% and 70.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the st
NGM Biopharmaceuticals (NGM) Reports Q2 Loss, Misses Revenue Estimates
10:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of -7.27% and 37.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022
02:30pm, Thursday, 04'th Aug 2022 Benzinga
Upgrades
UBS upgraded the previous rating for Southern Co (NYSE:SO) from Neutral to Buy. In the second quarter, Southern showed an EPS of $1.07, compared to $0.84 from the year-ago quarter. The curren
Fortress Biotech Appoints David Jin as Chief Financial Officer
12:00pm, Friday, 22'nd Jul 2022 GlobeNewswire Inc.
MIAMI, July 22, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress” or the “Company”), an innovative biopharmaceutical company focused on efficiently acquiring, develo
Fortress Biotech Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Dotinurad for the Treatment of Gout in the United States
12:30pm, Tuesday, 31'st May 2022 GlobeNewswire Inc.
Dotinurad is a potential best-in-class urate transporter (URAT1) inhibitor in clinical development at Fortress’ subsidiary company, UR-1 Therapeutics
Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference
12:30pm, Monday, 23'rd May 2022 GlobeNewswire Inc.
SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM), a commercial-stage pharmaceutical company that focuses on the development and
Fortress Biotech to Participate in Two Upcoming May 2022 Investor Conferences
12:30pm, Wednesday, 18'th May 2022 GlobeNewswire Inc.
MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializi
Fortress Biotech to Participate in Two Upcoming May 2022 Investor Conferences
08:30am, Wednesday, 18'th May 2022
MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing
Stocks To Watch: Retail Heavyweights Report, Block And Moderna Events
01:27pm, Saturday, 14'th May 2022 Seeking Alpha
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week
Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates
09:35pm, Thursday, 12'th May 2022 Zacks Investment Research
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 35.71% and 19.27%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates
06:48pm, Thursday, 12'th May 2022
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 35.71% and 19.27%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Misses Revenue Estimates
09:45pm, Monday, 09'th May 2022 Zacks Investment Research
Sutro Biopharma, Inc. (STRO) delivered earnings and revenue surprises of -6.33% and 48.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Journey Medical Corporation to Announce First Quarter 2022 Financial Results on May 10, 2022
08:15pm, Tuesday, 03'rd May 2022 GlobeNewswire Inc.
Company to host conference call to discuss financial results and provide a corporate update on May 10, 2022 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a c
Fortress Biotech to Present at the 21st Annual Needham Virtual Healthcare Conference
12:30pm, Thursday, 07'th Apr 2022 GlobeNewswire Inc.
MIAMI, April 07, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commerciali
Fortress Biotech to Present at the 21st Annual Needham Virtual Healthcare Conference
08:30am, Thursday, 07'th Apr 2022
MIAMI, April 07, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializi
